Walter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $45.95, for a total transaction of $919,000.00. Following the completion of the sale, the director now owns 3,580,857 shares of the company’s stock, valued at $164,540,379.15. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Simulations Plus Price Performance

SLP traded up $0.40 during trading on Thursday, reaching $46.72. 85,024 shares of the company’s stock were exchanged, compared to its average volume of 108,580. Simulations Plus, Inc. has a 1 year low of $32.69 and a 1 year high of $52.69. The stock has a market capitalization of $933.93 million, a P/E ratio of 87.40 and a beta of 0.68. The company’s fifty day simple moving average is $43.83 and its 200-day simple moving average is $41.10.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Wednesday, April 3rd. The technology company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.02. The firm had revenue of $18.31 million during the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a net margin of 16.22% and a return on equity of 7.95%. The business’s quarterly revenue was up 16.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.20 EPS. Equities analysts forecast that Simulations Plus, Inc. will post 0.67 EPS for the current year.

Simulations Plus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, May 6th. Stockholders of record on Monday, April 29th will be issued a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 0.51%. The ex-dividend date is Friday, April 26th. Simulations Plus’s dividend payout ratio (DPR) is 45.28%.

Analyst Ratings Changes

Separately, Craig Hallum raised their price target on shares of Simulations Plus from $50.00 to $51.00 and gave the stock a “buy” rating in a research report on Thursday, January 4th.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors have recently made changes to their positions in the company. Connecticut Wealth Management LLC purchased a new stake in Simulations Plus in the 1st quarter worth $204,000. Janney Montgomery Scott LLC purchased a new stake in Simulations Plus in the 1st quarter worth $208,000. BNP Paribas Financial Markets increased its holdings in Simulations Plus by 9.1% in the 1st quarter. BNP Paribas Financial Markets now owns 14,143 shares of the technology company’s stock worth $582,000 after acquiring an additional 1,174 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Simulations Plus in the 1st quarter worth $70,000. Finally, Principal Financial Group Inc. increased its holdings in Simulations Plus by 1.4% in the 1st quarter. Principal Financial Group Inc. now owns 88,142 shares of the technology company’s stock worth $3,627,000 after acquiring an additional 1,203 shares in the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.